Pharmacokinetics, pharmacodynamics, safety, and tolerability of pradigastat, a novel diacylglycerol acyltransferase 1 inhibitor in overweight or obese, but otherwise healthy human subjects

Publisher: John Wiley & Sons Inc

E-ISSN: 1552-4604|55|9|1031-1041

ISSN: 0091-2700

Source: JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.9, 2015-09, pp. : 1031-1041

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content